1. Home
  2. ALT vs HPP Comparison

ALT vs HPP Comparison

Compare ALT & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • HPP
  • Stock Information
  • Founded
  • ALT 1997
  • HPP 2009
  • Country
  • ALT United States
  • HPP United States
  • Employees
  • ALT N/A
  • HPP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • ALT Health Care
  • HPP Finance
  • Exchange
  • ALT Nasdaq
  • HPP Nasdaq
  • Market Cap
  • ALT 472.3M
  • HPP 453.1M
  • IPO Year
  • ALT N/A
  • HPP 2010
  • Fundamental
  • Price
  • ALT $6.43
  • HPP $3.01
  • Analyst Decision
  • ALT Strong Buy
  • HPP Hold
  • Analyst Count
  • ALT 7
  • HPP 11
  • Target Price
  • ALT $20.83
  • HPP $4.45
  • AVG Volume (30 Days)
  • ALT 2.0M
  • HPP 2.5M
  • Earning Date
  • ALT 02-27-2025
  • HPP 02-20-2025
  • Dividend Yield
  • ALT N/A
  • HPP 3.42%
  • EPS Growth
  • ALT N/A
  • HPP N/A
  • EPS
  • ALT N/A
  • HPP N/A
  • Revenue
  • ALT $52,000.00
  • HPP $842,082,000.00
  • Revenue This Year
  • ALT N/A
  • HPP N/A
  • Revenue Next Year
  • ALT N/A
  • HPP $0.36
  • P/E Ratio
  • ALT N/A
  • HPP N/A
  • Revenue Growth
  • ALT N/A
  • HPP N/A
  • 52 Week Low
  • ALT $5.28
  • HPP $2.39
  • 52 Week High
  • ALT $14.84
  • HPP $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ALT 42.82
  • HPP 48.49
  • Support Level
  • ALT $6.06
  • HPP $2.75
  • Resistance Level
  • ALT $7.10
  • HPP $3.26
  • Average True Range (ATR)
  • ALT 0.36
  • HPP 0.18
  • MACD
  • ALT 0.03
  • HPP -0.00
  • Stochastic Oscillator
  • ALT 33.33
  • HPP 47.22

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: